Bartering Your Eggs: A Rotten Deal
By Arthur Caplan and Gwendolyn P. Quinn,
Hastings Bioethics Forum
| 08. 17. 2023
The technology associated with assisted reproduction has grown exponentially in the last two decades. Planned oocyte and sperm freezing, posthumous reproductive genetic testing, and egg and donor sperm brokering are expanding infertility services. Demand has grown, as well. Estimates suggest there are now over one million donor-conceived children, about 10,000 per year. The use of donor gametes has allowed people with infertility or other medical conditions to achieve their parenthood goals.
The settings in which services are delivered are rapidly evolving, too. What was once only offered by academic and private medical facilities has become a burgeoning platform for start-ups, private equity firms, and international entrepreneurs. Corporations are offering insurance coverage for egg freezing for their young female employees. Around the country, egg freezing and egg shower parties market services to women. There are approximately 1,500 sperm banks and around 1,900 egg banks across the world with profits for sperm banks estimated at over $4 million in 2019 and for egg banks $487 million in the U.S. alone.
However, there is significant reproductive injustice and lack of access...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...